| 2026年中报 | 2025年年报 | 2025年中报 | 2025年一季报 | 2024年年报 | 2024年中报 | 2024年一季报 | |
|---|---|---|---|---|---|---|---|
| 营业收入(元) | |||||||
| 数字化医药分销与供应链业务(元) | - | - | - | - | - | - | 33,803,000,000.00 |
| 数字物流技术与供应链解决方案(元) | - | - | - | - | - | - | 202,000,000.00 |
| 医疗健康与技术增值服务(元) | - | - | - | - | - | - | 47,000,000.00 |
| 医药工业自产及OEM业务(元) | - | - | - | - | 3,007,498,300.00 | - | 717,000,000.00 |
| 医药新零售业务(元) | - | - | - | - | - | - | 676,000,000.00 |
| 总代品牌推广业务(元) | - | - | - | - | 19,267,452,200.00 | - | 5,002,000,000.00 |
| 分销(元) | 83,204,292,742.16 | 154,734,729,353.78 | 77,811,548,465.57 | - | 125,159,041,600.00 | 74,113,543,419.67 | - |
| 医疗健康分部(元) | 418,174,358.48 | 304,946,703.43 | 140,159,871.78 | - | - | 103,420,267.05 | - |
| 医药工业(元) | 1,982,343,097.96 | 3,332,725,898.93 | 1,592,640,725.24 | 726,000,000.00 | - | 1,437,782,191.99 | - |
| 医药零售(元) | 1,583,747,803.50 | 2,878,603,817.34 | 1,493,031,537.36 | 834,000,000.00 | 2,965,838,400.00 | 1,456,323,859.52 | - |
| 三方物流业务(元) | - | - | - | - | 1,063,510,800.00 | - | - |
| 医疗健康及技术服务(元) | - | - | - | 70,000,000.00 | 231,328,700.00 | - | - |
| 医药批发及相关业务(元) | - | - | - | 40,352,000,000.00 | - | - | - |
| 营业成本(元) | |||||||
| 数字化医药分销与供应链业务(元) | - | - | - | - | - | - | 31,942,000,000.00 |
| 数字物流技术与供应链解决方案(元) | - | - | - | - | - | - | 159,000,000.00 |
| 医疗健康与技术增值服务(元) | - | - | - | - | - | - | 30,000,000.00 |
| 医药工业自产及OEM业务(元) | - | - | - | - | 2,354,017,100.00 | - | 561,000,000.00 |
| 医药新零售业务(元) | - | - | - | - | - | - | 582,000,000.00 |
| 总代品牌推广业务(元) | - | - | - | - | 17,107,546,100.00 | - | 4,268,000,000.00 |
| 分销(元) | 77,249,303,207.72 | 143,452,544,474.78 | 72,299,237,604.26 | - | 116,904,296,500.00 | 68,580,880,454.79 | - |
| 医疗健康分部(元) | 220,275,365.88 | 166,924,122.61 | 83,018,126.80 | - | - | 67,419,024.38 | - |
| 医药工业(元) | 1,614,361,589.17 | 2,690,559,078.59 | 1,272,568,894.17 | 580,000,000.00 | - | 1,123,851,122.32 | - |
| 医药零售(元) | 1,346,877,366.30 | 2,442,213,698.62 | 1,275,165,065.93 | 734,000,000.00 | 2,563,231,700.00 | 1,253,257,058.99 | - |
| 三方物流业务(元) | - | - | - | - | 827,486,700.00 | - | - |
| 医疗健康及技术服务(元) | - | - | - | 43,000,000.00 | 143,875,900.00 | - | - |
| 医药批发及相关业务(元) | - | - | - | 37,559,000,000.00 | - | - | - |
| 毛利(元) | |||||||
| 数字化医药分销与供应链业务(元) | - | - | - | - | - | - | 1,861,000,000.00 |
| 数字物流技术与供应链解决方案(元) | - | - | - | - | - | - | 43,000,000.00 |
| 医疗健康与技术增值服务(元) | - | - | - | - | - | - | 17,000,000.00 |
| 医药工业自产及OEM业务(元) | - | - | - | - | 653,481,200.00 | - | 156,000,000.00 |
| 医药新零售业务(元) | - | - | - | - | - | - | 94,000,000.00 |
| 总代品牌推广业务(元) | - | - | - | - | 2,159,906,100.00 | - | 734,000,000.00 |
| 分销(元) | 5,954,989,534.44 | 11,282,184,879.00 | 5,512,310,861.31 | - | 8,254,745,100.00 | 5,532,662,964.88 | - |
| 医疗健康分部(元) | 197,898,992.60 | 138,022,580.82 | 57,141,744.98 | - | - | 36,001,242.67 | - |
| 医药工业(元) | 367,981,508.79 | 642,166,820.34 | 320,071,831.07 | 146,000,000.00 | - | 313,931,069.67 | - |
| 医药零售(元) | 236,870,437.20 | 436,390,118.72 | 217,866,471.43 | 100,000,000.00 | 402,606,700.00 | 203,066,800.53 | - |
| 三方物流业务(元) | - | - | - | - | 236,024,100.00 | - | - |
| 医疗健康及技术服务(元) | - | - | - | 27,000,000.00 | 87,452,800.00 | - | - |
| 医药批发及相关业务(元) | - | - | - | 2,793,000,000.00 | - | - | - |
| 毛利率(%) | |||||||
| 数字化医药分销与供应链业务(%) | - | - | - | - | - | - | 5.51 |
| 数字物流技术与供应链解决方案(%) | - | - | - | - | - | - | 21.29 |
| 医疗健康与技术增值服务(%) | - | - | - | - | - | - | 36.17 |
| 医药工业自产及OEM业务(%) | - | - | - | - | 21.73 | - | 21.76 |
| 医药新零售业务(%) | - | - | - | - | - | - | 13.91 |
| 总代品牌推广业务(%) | - | - | - | - | 11.21 | - | 14.67 |
| 分销(%) | 7.16 | 7.29 | 7.08 | - | 6.60 | 7.47 | - |
| 医疗健康分部(%) | 47.32 | 45.26 | 40.77 | - | - | 34.81 | - |
| 医药工业(%) | 18.56 | 19.27 | 20.10 | 20.11 | - | 21.83 | - |
| 医药零售(%) | 14.96 | 15.16 | 14.59 | 11.99 | 13.57 | 13.94 | - |
| 三方物流业务(%) | - | - | - | - | 22.19 | - | - |
| 医疗健康及技术服务(%) | - | - | - | 38.57 | 37.80 | - | - |
| 医药批发及相关业务(%) | - | - | - | 6.92 | - | - | - |
| 收入构成(%) | |||||||
| 数字化医药分销与供应链业务(%) | - | - | - | - | - | - | 83.57 |
| 数字物流技术与供应链解决方案(%) | - | - | - | - | - | - | 0.50 |
| 医疗健康与技术增值服务(%) | - | - | - | - | - | - | 0.12 |
| 医药工业自产及OEM业务(%) | - | - | - | - | 1.98 | - | 1.77 |
| 医药新零售业务(%) | - | - | - | - | - | - | 1.67 |
| 总代品牌推广业务(%) | - | - | - | - | 12.70 | - | 12.37 |
| 分销(%) | 95.43 | 95.96 | 96.02 | - | 82.51 | 96.11 | - |
| 医疗健康分部(%) | 0.48 | 0.19 | 0.17 | - | - | 0.13 | - |
| 医药工业(%) | 2.27 | 2.07 | 1.97 | 1.73 | - | 1.86 | - |
| 医药零售(%) | 1.82 | 1.79 | 1.84 | 1.99 | 1.96 | 1.89 | - |
| 三方物流业务(%) | - | - | - | - | 0.70 | - | - |
| 医疗健康及技术服务(%) | - | - | - | 0.17 | 0.15 | - | - |
| 医药批发及相关业务(%) | - | - | - | 96.12 | - | - | - |
| 毛利构成(%) | |||||||
| 数字化医药分销与供应链业务(%) | - | - | - | - | - | - | 64.06 |
| 数字物流技术与供应链解决方案(%) | - | - | - | - | - | - | 1.48 |
| 医疗健康与技术增值服务(%) | - | - | - | - | - | - | 0.59 |
| 医药工业自产及OEM业务(%) | - | - | - | - | 5.54 | - | 5.37 |
| 医药新零售业务(%) | - | - | - | - | - | - | 3.24 |
| 总代品牌推广业务(%) | - | - | - | - | 18.31 | - | 25.27 |
| 分销(%) | 88.12 | 90.27 | 90.26 | - | 69.99 | 90.91 | - |
| 医疗健康分部(%) | 2.93 | 1.10 | 0.94 | - | - | 0.59 | - |
| 医药工业(%) | 5.45 | 5.14 | 5.24 | 4.76 | - | 5.16 | - |
| 医药零售(%) | 3.51 | 3.49 | 3.57 | 3.26 | 3.41 | 3.34 | - |
| 三方物流业务(%) | - | - | - | - | 2.00 | - | - |
| 医疗健康及技术服务(%) | - | - | - | 0.88 | 0.74 | - | - |
| 医药批发及相关业务(%) | - | - | - | 91.10 | - | - | - |